Details of the Drug | DrugMAP

General Information of Drug (ID: DMTEQEQ)

Drug Name

Galinpepimut-S

Indication

Disease Entry	ICD 11	Status	REF
Acute myeloid leukaemia	2A60	Phase 3	[1]
Chronic myeloid leukaemia	2A20	Phase 2	[2]
Malignant pleural mesothelioma	2C26.0	Phase 2	[3]
Mesothelioma	2C51.2	Phase 2	[2]
Multiple myeloma	2A83	Phase 2	[3]
Ovarian cancer	2C73	Phase 2	[2]
Chronic myelogenous leukaemia	2A20.0	Phase 1/2	[3]
------------------------------------------------------------------------------------


⏷ Show the Full List of Indication(s)

Cross-matching ID

TTD ID: D0M9OO

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT04229979) GPS Compared With BAT in AML CR2/CR2p. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)